Key Takeaways
- Teflaro (ceftaroline fosamil) is a fifth-generation cephalosporin antibiotic used to treat acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia caused by designated susceptible bacteria.
- Teflaro works by binding to penicillin-binding proteins involved in bacterial cell-wall synthesis, providing bactericidal activity against susceptible bacteria, including susceptible MRSA strains in certain skin infections.
- Prescription Hope may help eligible patients navigate medication assistance options and access support for prescribed medications such as Teflaro.
Introduction
Teflaro (ceftaroline fosamil) is an intravenous beta-lactam antibiotic used to treat certain bacterial infections. It is approved for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia caused by designated susceptible bacteria in adults and specified pediatric populations.
When the cost or complexity of prescription treatment creates an additional challenge, Prescription Hope may help eligible patients navigate medication assistance options. Its advocates can provide support throughout the process of seeking assistance for medications such as Teflaro.
What Is the Teflaro Patient Assistance Program?
Understanding Teflaro Prescription Assistance
Patient assistance programs help eligible patients who have difficulty affording prescribed medications. The Teflaro patient assistance program offers qualified patients access to affordable Teflaro.
Manufacturers often provide patient assistance programs for their brand-name products to help patients struggling to afford their medications.
Prescription Hope provides support for patients seeking medication assistance through patient assistance programs and helps simplify the process of navigating applicable assistance programs.
Eligibility requirements vary by program. Patients may need to provide information regarding their prescription, insurance status, income, and other circumstances. Prescription Hope advocates can help patients understand the application process and coordinate the information needed to seek assistance.
How Expert Advocates Help Make Teflaro More Affordable
Personalized Medication Assistance
Prescription Hope patient advocates can help eligible patients navigate the process of seeking medication assistance for Teflaro. This may include helping patients understand application requirements, gathering required documentation, and coordinating information between the patient, healthcare provider, and applicable assistance program.
Personalized support can make the administrative side of seeking medication assistance easier to navigate.
Ongoing Patient Support
Medication assistance through patient assistance programs can involve more than an initial application. Patients may need continued help with documentation, renewals, or other program requirements.
Prescription Hope provides ongoing support to help eligible patients navigate these requirements and continue seeking access to prescription medications when applicable program criteria are met.
Teflaro Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Treatment Costs
The cost of prescription treatment can be a concern for patients managing bacterial infections. Prescription Hope may help eligible patients navigate medication assistance options for Teflaro.
Prescription Hope’s service is available at $70.00 per month, per medication. Patients must still meet the applicable requirements for medication assistance.
Teflaro Patient Assistance Eligibility
General Eligibility Requirements
Eligibility for medication assistance varies by program. General factors that may be considered include income, insurance status, having a valid prescription, and U.S. residency.
Prescription Hope can help patients understand the information that may be required when seeking assistance. Submitting an application does not guarantee approval, and patients must meet the requirements of the applicable assistance program.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Prescription Hope helps simplify the process of seeking prescription assistance by guiding patients through the necessary steps:
- Submit Information: Provide the information needed to begin the assistance process.
- Advocate Contact: A Prescription Hope advocate reviews the information and helps explain the next steps.
- Document Collection: Gather the required patient and prescription documentation.
- Provider Coordination: Prescription Hope may coordinate with the healthcare provider when additional information is needed.
- Program Submission: Required materials are submitted to the applicable medication assistance program.
- Medication Delivery: If the patient qualifies and the application is approved, the medication can proceed through the applicable fulfillment process.
Understanding Teflaro
How Teflaro Works
Teflaro contains ceftaroline fosamil, a prodrug that is converted to the active antibacterial form, ceftaroline. Ceftaroline binds to essential penicillin-binding proteins involved in bacterial cell-wall synthesis, producing bactericidal activity.
Ceftaroline also binds to PBP2a, the altered protein associated with methicillin resistance in Staphylococcus aureus. This provides activity against susceptible MRSA strains. Ceftaroline also has activity against PBP2x in Streptococcus pneumoniae.
What Conditions Does Teflaro Treat?
This medication is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.
For ABSSSI, labeled susceptible organisms include Staphylococcus aureus, including MRSA, Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca.
For CABP, labeled organisms include Streptococcus pneumoniae, Staphylococcus aureus (MSSA only), Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli.
Teflaro is approved for adults and specified pediatric populations. ABSSSI treatment includes pediatric patients at least 34 weeks gestational age and 12 days postnatal age, while CABP treatment includes pediatric patients 2 months of age and older.
Benefits of Treatment
Teflaro provides intravenous antibacterial treatment for susceptible bacterial skin infections and community-acquired bacterial pneumonia. Its activity against susceptible MRSA is an important characteristic in the treatment of designated ABSSSI infections.
In adult Phase 3 ABSSSI trials, clinical cure rates at the test-of-cure visit were approximately 85% to 92% across Teflaro treatment groups. In CABP trials, Teflaro demonstrated clinical outcomes comparable to ceftriaxone in the studied populations.
Important Safety Information and Side Effects
Teflaro does not have a boxed warning. However, the medication has important warnings and precautions that should be discussed with a healthcare professional.
Serious Hypersensitivity Reactions
Serious allergic reactions, including anaphylaxis, can occur with Teflaro. The risk is particularly important in patients with a history of beta-lactam allergy.
It is contraindicated in patients with a known serious hypersensitivity to ceftaroline or other cephalosporin antibiotics.
Clostridioides Difficile-Associated Diarrhea
Antibiotic-associated diarrhea and colitis can occur with this medication, including severe or potentially fatal cases.
Neurological Adverse Reactions
Encephalopathy and seizures have been reported with this medication, particularly in patients with renal impairment who did not receive appropriate dosage adjustment.
Direct Coombs’ Test Seroconversion
Teflaro can cause a positive direct Coombs’ test. If anemia develops during or after treatment, drug-induced hemolytic anemia should be evaluated and discontinuation considered.
Antimicrobial Resistance
Teflaro should be used only when a bacterial infection is proven or strongly suspected to be caused by susceptible organisms.
Teflaro should not be considered broadly active against all resistant Gram-negative organisms. The medication is not active against organisms producing certain extended-spectrum beta-lactamases (ESBLs), KPC carbapenemases, metallo-beta-lactamases, or AmpC cephalosporinases.
Common Side Effects
In adults, the most common adverse reactions occurring in more than 2% of patients include:
- Diarrhea
- Nausea
- Rash
- Constipation
- Vomiting
- Increased transaminases
- Hypokalemia
- Phlebitis
In pediatric patients, the most common adverse reactions occurring in at least 3% include:
- Diarrhea
- Rash
- Vomiting
- Nausea
- Fever
Pregnancy and Breastfeeding
There are no adequate and well-controlled studies of Teflaro in pregnant women. Animal studies did not demonstrate malformations or other adverse developmental effects at exposures up to approximately four times the maximum recommended human dose.
There are no data regarding the presence of ceftaroline in human milk or its effects on breastfed infants or milk production. The benefits of breastfeeding should be weighed against the mother’s clinical need for this medication and potential effects on the breastfed child.
Access to Multiple Medications
Support Beyond Teflaro
Patients seeking assistance with Teflaro may also need support accessing other prescription medications. Prescription Hope can help eligible patients navigate medication assistance options beyond a single prescription. With a list of hundreds of medications available for access, Prescription Hope often helps qualified patients access all of their needed brand-name medications for a simple $70.00 per month, per medication.
Why Choose Prescription Hope for Medication Assistance
Patient-Focused Medication Support
Prescription Hope provides patient-focused support for people seeking assistance with prescription medications. Advocates can help eligible patients navigate the application process and understand the information needed to seek medication assistance.
Simplified Access to Specialty Therapies
Prescription medications can involve different requirements and administrative steps depending on the medication and assistance program. Prescription Hope may help eligible patients simplify the process of seeking medication assistance services.
Ongoing Prescription Assistance
Prescription Hope’s support can extend beyond the initial application process. Eligible patients may receive ongoing assistance as they navigate documentation, renewals, and other requirements associated with prescription assistance.
For patients prescribed Teflaro, this support can simplify the administrative process of seeking medication assistance while they focus on treatment.